APA (7th ed.) Citation

JT, D., K, T., NR, R., M, W., JD, C., & MS, S. (2026). Chronic oral cannabidiol delays seizure onset and reduces seizure burden in a mouse model of CLN2 disease. PloS one, 21(7), e0337880. https://doi.org/10.1371/journal.pone.0337880

Chicago Style (17th ed.) Citation

JT, Dearborn, Takahashi K, Rensing NR, Wong M, Cooper JD, and Sands MS. "Chronic Oral Cannabidiol Delays Seizure Onset and Reduces Seizure Burden in a Mouse Model of CLN2 Disease." PloS One 21, no. 7 (2026): e0337880. https://doi.org/10.1371/journal.pone.0337880.

MLA (9th ed.) Citation

JT, Dearborn, et al. "Chronic Oral Cannabidiol Delays Seizure Onset and Reduces Seizure Burden in a Mouse Model of CLN2 Disease." PloS One, vol. 21, no. 7, 2026, p. e0337880, https://doi.org/10.1371/journal.pone.0337880.